Journals / Respiratory Case Reports / 2022 / Cilt: 11 - Sayı: 1

Delayed Pulmonary Embolism after Mild COVID-19: A Case Report

Hafif COVID-19 Sonrası Gecikmiş Pulmoner Emboli: Olgu Sunumu

Pages
19–24
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In conclusion, an unusually longer activation in COVID-19 coagulopathy may co-exist in patients with a history of previous PE, on-going symptoms and increased D-dimer levels, irre-spective of the COVID-19 severity.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:COVID-19 coagulopathy has gained attention due to the strikingly high prevalence of deep vein thrombosis (DVT) and pulmonary embolism (PE).
📊
Key Findings & Data:We describe here a case of bilateral PE preceded by mild COVID-19 contracted 4.5 months earlier in a male patient who presented to the outpatient clinic with exertional dyspnea.
💡
Conclusion & Impact:In conclusion, an unusually longer activation in COVID-19 coagulopathy may co-exist in patients with a history of previous PE, on-going symptoms and increased D-dimer levels, irre-spective of the COVID-19 severity.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

COVID-19 coagulopathy has gained attention due to the strikingly high prevalence of deep vein thrombosis (DVT) and pulmonary embolism (PE). We describe here a case of bilateral PE preceded by mild COVID-19 contracted 4.5 months earlier in a male patient who presented to the outpatient clinic with exertional dyspnea. The patient had developed PE 9 years earli-er, when no underlying genetic factor was detected. In the 4.5 months after contracting mild COVID-19, he presented four times with exertional dyspnea and a thorax computer tomography angiography (CTA) on two occasions and one perfusion scintigraphy revealed no embolism. Based on his high D-dimer values, his symptoms and his history of PE, he was placed on prolonged PE prophylaxis, which was stopped 33 days ago, and at that time, CTA revealed extensive bilateral PE. In conclusion, an unusually longer activation in COVID-19 coagulopathy may co-exist in patients with a history of previous PE, on-going symptoms and increased D-dimer levels, irre-spective of the COVID-19 severity.

Özet

Yeni koronavirüs hastalığı (COVID-19) derin ven trombozu (DVT) ve pulmoner emboli (PE) sıklığında artış ile ilişkilendirilen koagülopati ile dikkat çekmiştir. Bu olgu sunumunda hafif COVID-19 sonrası sapta-nan bilateral yaygın PE olgusu tartışılmıştır. Elli yedi yaşında, eforla artan nefes darlığı şikayetiyle polikli-niğimize başvurdu. Dokuz yıl önce PE geçirmiş, gene-tik bir risk faktörü saptanmamıştı. Dört buçuk ay önce COVID-19 tanısı konulmuş, hafif semptomlar ile düzelmişti. Daha sonra dört kez efor dispnesi nede-niyle polikliniğimize başvurmuş, diğer nedenler dış-lanmış, yüksek d-dimer düzeyleri nedeniyle çekilen iki toraks bilgisayarlı tomografi anjiyografi (BTA) ve perfüzyon sintigrafisinde emboli saptanmamıştı. Uzun süre devam edilen PE profilaktik tedavisi 33 gün önce kesilmişti. D-dimer düzeyinde artış nedeniyle yeniden BTA çekilen hastada bilateral ana pulmoner arterler-de trombüs saptandı. Sonuç olarak, hafif COVID-19 hastalığı geçiren hastalarda dahi, devam eden semp-tomlar, yüksek D-dimer düzeyleri ve daha önceki PE öyküsü; daha uzun süren COVID-19 koagülopatisi için uyarıcı olabilir.

🔖

Cite This Article

AKYIL, F. T., VESKE, N. Ş., KARA, K., ÖNÜR, S. T., DOĞRU, M. V., ARSLAN, M. A., KILINÇARSLAN, K. G. (2022). Delayed Pulmonary Embolism after Mild COVID-19: A Case Report. Respiratory Case Reports, Cilt: 11 - Sayı: 1, 19–24. https://ajindex.com/articles/588864

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E, et al. COVID-19 and thrombotic or thrombo-embolic disease: implications for prevention, antithrom-botic therapy, and follow-up: JACC state-of-theart review. J Am Coll Cardiol 2020; 75:2950-73. [CrossRef] 2. Sanidas E, Grassos C, Papadopoulos D, Velliou M, Bar-betseas J. Pulmonary embolism prophylaxis in patients with COVID-19: an emerging issue. Heart Lung Circ 2021; 30:1435-41. [CrossRef] 3. Kosior DA, Undas A, Kopec G, Hryniewiecki T, Torbicki A, Mularek Kubzdela T, et al. Guidance for anticoagulation management in venous thromboembolism during the co-ronavirus disease 2019 (COVID-19) pandemic in Poland: an expert opinion of the Section on Pulmonary Circula-tion of the Polish Cardiac Society. Kardiol Pol 2020; 78:642-6. [CrossRef] 4. Barnes G, Burnett A, Allen A, Blumenstein M, Clark NP, Cuker A, et al. Thromboembolism and anticoagulant the-rapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum. J Thromb Thrombolysis 2020; 50:72-81. [CrossRef] 5. Lazaridis D, Leung S, Kohler L, Smith CH, Kearson ML, Eraikhuemen N. The impact of anticoagulation on COVID-19 (SARS CoV-2) patient outcomes: a systematic review. J Pharm Pract 2021; 8971900211015055. [CrossRef] 6. Patell R, Bogue T, Koshy A, Bindal P, Merrill M, Aird WC, et al. Postdischarge thrombosis and hemorrhage in pati-ents with COVID-19. Blood 2020; 136:1342-6. [CrossRef] 7. National Institutes of Health. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. Available at: https://www.covid19treatmentguidelines.nih.gov. [acces-sed at 5.5.21]. 8. Engelen MM, Vandenbriele C, Balthazar T, Claeys E, Gunst J, Guler I, et al. Incidence of venous thromboem-bolism in patients discharged after COVID-19 hospitali-zation. Semin Tromb Hemost 2021; 47:362-71. [CrossRef] 9. Fan BE, Umapathi T, Chua K, Chia YW, Wong SW, Tan GWL, et al. Delayed catastrophic thrombotic events in young and asymptomatic post COVID-19 patients. J Thromb Thrombolysis 2021; 51:971-7. [CrossRef] 10. Singh A, Patel Y, Zatakia J, Steiger D. Acute venous thromboembolism occuring many months following acute COVID-19. Am J Respir Crit Care Med 2021; 203:A3727. [CrossRef] 11. Becker RC. Anticipating the long-term cardiovascular ef-fects of COVID-19. J Thromb Thrombolysis 2020; 50:512-24. [CrossRef] 12. Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post- acute COVID-19 syndrome. Nat Med 2021; 27:601-15. [CrossRe